Aggregate Standard & Poor's Rated U.S. CDO Data: First-Quarter 2011

  • ID: 1783073
  • May 2011
  • Standard & Poors
1 of 2

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

The tables below provide aggregate statistics for Standard & Poor's Ratings Services' universe of outstanding rated U.S. collateralized debt obligation (CDO) transactions as of the end of first-quarter 2011. The tables show the dollar amount of issuance (in billions) for U.S. cash flow and hybrid, synthetic, and market-value CDO transactions, as well as the number of active transactions at the end of the quarter. We intend to continue to publish updated U.S. CDO transaction statistics following the end of each quarter....

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.